Cycurion receives Nasdaq delisting notice
Analysis based on 18 articles · First reported Jul 16, 2026 · Last updated Jul 16, 2026
The delisting notice negatively impacts Cycurion's stock price and investor confidence, potentially leading to reduced liquidity and access to capital markets. However, the company's strong revenue run rate and ongoing operations may mitigate long-term effects if it successfully appeals or regains compliance.
Cycurion, Inc. (NASDAQ: CYCU) received a delisting determination letter from Nasdaq on July 10, 2026, due to its common stock closing bid price falling below $1.00 per share for 31 consecutive business days from May 26 to July 9, 2026. Because Cycurion had effected a 1-for-30 reverse stock split on October 27, 2025, it is not eligible for the customary 180-day compliance period. Trading is expected to be suspended on July 21, 2026, unless a timely hearing request is made. Cycurion plans to request a hearing before the Nasdaq Hearings Panel by the July 17, 2026 deadline, which will stay the suspension pending a decision. The company's Board of Directors has decided not to pursue another reverse stock split at this time and is evaluating other options to regain compliance. Cycurion continues to operate normally, with an annual revenue run rate exceeding $28 million and a strong contracted backlog.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard